Page last updated: 2024-08-17

androstenedione and pioglitazone

androstenedione has been researched along with pioglitazone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ciampelli, M; Giuliani, M; Guido, M; Lanzone, A; Leoni, F; Perri, C; Romualdi, D	1
Apa, R; Costantini, B; Giuliani, M; Guido, M; Lanzone, A; Romualdi, D; Suriano, R	1
Archer, JS; Chang, RJ; Coffler, MS; Dahan, MH; Malcom, PJ; Mehta, RV; Patel, KS; Yoo, RY	1

Trials

2 trial(s) available for androstenedione and pioglitazone

Article	Year
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Human reproduction (Oxford, England), 2003, Volume: 18, Issue:6 Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgens; Androstenedione; Body Constitution; Body Mass Index; Female; Follicle Stimulating Hormone; Glucose Clamp Technique; Glucose Tolerance Test; Hirsutism; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones	2003
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome. Human reproduction (Oxford, England), 2004, Volume: 19, Issue:3 Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Thiazolidinediones	2004

Article

Year

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

Human reproduction (Oxford, England), 2003, Volume: 18, Issue:6

Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgens; Androstenedione; Body Constitution; Body Mass Index; Female; Follicle Stimulating Hormone; Glucose Clamp Technique; Glucose Tolerance Test; Hirsutism; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Thiazolidinediones

2003

Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.

Human reproduction (Oxford, England), 2004, Volume: 19, Issue:3

Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androgens; Androstenedione; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Steroid 17-alpha-Hydroxylase; Thiazolidinediones

2004

Other Studies

1 other study(ies) available for androstenedione and pioglitazone

Article	Year
Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:4 Topics: Adult; Androstenedione; Female; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Pioglitazone; Polycystic Ovary Syndrome; Testosterone; Thiazolidinediones	2005

Article

Year

Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment.

The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:4

Topics: Adult; Androstenedione; Female; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Luteinizing Hormone; Pioglitazone; Polycystic Ovary Syndrome; Testosterone; Thiazolidinediones

2005